Campaign for Access to Essential Medicines (Paperback)


Please note that the content of this book primarily consists of articles available from Wikipedia or other free sources online. The Campaign for Access to Essential Medicines is an international campaign started by M decins Sans Fronti res (MSF) to increase the availability of essential medicines in developing countries. MSF often has difficulties treating patients because the medicines required are too expensive or are no longer produced. Sometimes, the only drugs available are highly toxic or ineffective, and they often have to resort to inadequate testing methods to diagnose patients. The lack of research into diseases that affect most of the world's poor population is known as the 10-90 gap and it occurs because pharmaceutical companies rarely make a profit when developing drugs for these diseases. Although some countries have created legislation to encourage development of essential medicines, which are called orphan drugs in the United States, MSF started this campaign in November 1999 to bring more awareness to the issue, using its prize money from its 1999 Nobel Peace Prize to fund the project.

R878

Or split into 4x interest-free payments of 25% on orders over R50
Learn more

Discovery Miles8780
Mobicred@R82pm x 12* Mobicred Info
Free Delivery
Delivery AdviceOut of stock

Toggle WishListAdd to wish list
Review this Item

Product Description

Please note that the content of this book primarily consists of articles available from Wikipedia or other free sources online. The Campaign for Access to Essential Medicines is an international campaign started by M decins Sans Fronti res (MSF) to increase the availability of essential medicines in developing countries. MSF often has difficulties treating patients because the medicines required are too expensive or are no longer produced. Sometimes, the only drugs available are highly toxic or ineffective, and they often have to resort to inadequate testing methods to diagnose patients. The lack of research into diseases that affect most of the world's poor population is known as the 10-90 gap and it occurs because pharmaceutical companies rarely make a profit when developing drugs for these diseases. Although some countries have created legislation to encourage development of essential medicines, which are called orphan drugs in the United States, MSF started this campaign in November 1999 to bring more awareness to the issue, using its prize money from its 1999 Nobel Peace Prize to fund the project.

Customer Reviews

No reviews or ratings yet - be the first to create one!

Product Details

General

Imprint

Anim Publishing

Country of origin

United States

Release date

December 2011

Availability

Supplier out of stock. If you add this item to your wish list we will let you know when it becomes available.

First published

December 2011

Editors

Dimensions

229 x 152 x 4mm (L x W x T)

Format

Paperback - Trade

Pages

72

ISBN-13

978-6200056542

Barcode

9786200056542

Categories

LSN

6200056544



Trending On Loot